Lupin 2023

inversion deals

Pfizer, Allergan merger aborted

NEW YORK — Pfizer Inc. and Allergan PLC have, by mutual agreement, terminated their planned merger. Pfizer management attributed the decision to new tax rules issued by the Treasury Department that are specifically intended to make such combinations less ­attractive. Under the proposed merger, Pfizer would have shifted its corporate address — but not its